soul semaglutide Trial (NEJM 2025): Oral led to a 14% ↓ in major CV events vs placebo in T2DM with ASCVD or CKD — no ↑ in serious AEs. #Semaglutide #CardioDiabetes #updatesinmedicine We are delighted to congratulate

Abrupt discontinuation can trigger appetite rebound within days

Millions of Americans take levothyroxine for hypothyroidism, and many are also candidates for GLP-1 weight loss therapy

A separate randomized, double-blind, placebo-controlled trial published in Nutrients found that five weeks of L-Carnitine tartrate supplementation may support recovery, reduce perceived soreness, and help blunt declines in strength and power following intense exercise challenges

The pharmacist processes it as a secondary claim after running the primary insurance

Some providers are highly knowledgeable about compounded medications within their specialty, while others may have had limited exposure to these options in their training or practice, says Hagen, adding that in many cases, the pharmacist and provider will discuss a specific case or condition and work together to develop a compounded medication that meets the patients needs

Bariatric surgery remains highly effective for severe obesity, with sustained weight loss of 5070% in many patients, though surgery carries its own risks and recovery period